Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines

被引:7
|
作者
Essogmo, Freddy Elad [1 ,2 ]
Zhilenkova, Angelina V. [1 ]
Tchawe, Yvan Sinclair Ngaha [1 ]
Owoicho, Abah Moses [1 ]
Rusanov, Alexander S. [1 ]
Boroda, Alexander [1 ]
Pirogova, Yuliya N. [1 ]
Sangadzhieva, Zaiana D. [1 ]
Sanikovich, Varvara D. [1 ]
Bagmet, Nikolay N. [3 ]
Sekacheva, Marina I. [1 ]
机构
[1] Sechenov Univ, Moscow State Med Univ 1, Inst Personalized Oncol, Ctr Digital Biodesign & Personalized Healthcare,Mi, Moscow 119991, Russia
[2] Cameroon Oncol Ctr COC, POB 1864, Douala, Cameroon
[3] Petrovsky Natl Res Ctr Surg, Moscow 119435, Russia
关键词
lung cancer; cytokines; therapy; immune system; anti-tumor; TGF-BETA; IMMUNOTHERAPY; ROLES; INTERLEUKIN-10; INFLAMMATION; IMMUNITY; BIOLOGY; CELLS;
D O I
10.3390/cancers15225383
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Lung cancer is currently the second leading cause of cancer death worldwide. Cytokines are small proteins that carry messages between cells and are known to play an important role in the body's response to inflammation and infection. Cytokines are important for immunity in lung cancer. The immune system relies heavily on cytokines which can also be produced in the laboratory for therapeutic use. Cytokine therapy helps the immune system to stop the growth or kill cancer cells including lung cancer cells. High doses of cytokines are required to induce a beneficial response in cancer patients, but doing so leads to many problems, including their short lifespan and toxicity. New technologies are being developed to help improve the targeting of cytokines and alter their side effects.Abstract Lung cancer is currently the second leading cause of cancer death worldwide. In recent years, checkpoint inhibitor immunotherapy (ICI) has emerged as a new treatment. A better understanding of the tumor microenvironment (TMJ) or the immune system surrounding the tumor is needed. Cytokines are small proteins that carry messages between cells and are known to play an important role in the body's response to inflammation and infection. Cytokines are important for immunity in lung cancer. They promote tumor growth (oncogenic cytokines) or inhibit tumor growth (anti-tumour cytokines) by controlling signaling pathways for growth, proliferation, metastasis, and apoptosis. The immune system relies heavily on cytokines. They can also be produced in the laboratory for therapeutic use. Cytokine therapy helps the immune system to stop the growth or kill cancer cells. Interleukins and interferons are the two types of cytokines used to treat cancer. This article begins by addressing the role of the TMJ and its components in lung cancer. This review also highlights the functions of various cytokines such as interleukins (IL), transforming growth factor (TGF), and tumor necrosis factor (TNF).
引用
收藏
页数:17
相关论文
共 50 条
  • [1] THE CHARACTERIZATION OF THE PHARMACOKINETIC PROFILE OF ANTI-TUMOR B (ATB) IN ORAL CANCER PATIENTS
    Chen, Jie
    Zheng, Zicong
    Srinual, Songpol
    Sun, Rongjin
    Yin, Taijun
    Saponjac, Vesna Tumbas
    Singh, Rashim
    You, Ming
    Wong, Stuart
    Hu, Ming
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
  • [2] Fuzi Enhances Anti-Tumor Efficacy of Radiotherapy on Lung Cancer
    Zhang, Qi
    Chen, Xue
    Luo, Youjun
    Ren, Huaping
    Qiao, Tiankui
    JOURNAL OF CANCER, 2017, 8 (19): : 3945 - 3951
  • [3] Cytokine Adjuvanation of Therapeutic Anti-tumor Immunity Targeted to Cancer Mucosa Antigens
    Snook, Adam E.
    Huang, Lan
    Schulz, Stephanie
    Eisenlohr, Laurence C.
    Waldman, Scott A.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2008, 1 (03): : 263 - 264
  • [4] Anti-tumor efficacy of paclitaxel against human lung cancer xenografts
    Yamori, T
    Sato, S
    Chikazawa, H
    Kadota, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (12): : 1205 - 1210
  • [5] Interleukin-12, a new anti-tumor cytokine
    Mier, JW
    Gollob, JA
    Atkins, MB
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 1998, 11 (03) : 109 - 115
  • [6] Anti-Tumor Effects of Cardiac Glycosides on Human Lung Cancer Cells and Lung Tumorspheres
    Kaushik, Vivek
    Yakisich, Juan Sebastian
    Azad, Neelam
    Kulkarni, Yogesh
    Venkatadri, Rajkumar
    Wright, Clayton
    Rojanasakul, Yon
    Iyer, Anand Krishnan V.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2017, 232 (09) : 2497 - 2507
  • [7] Parity improves anti-tumor immunity in breast cancer patients
    Krause, Anna-Lena
    Schuetz, Florian
    Boudewijns, Marc
    Pritsch, Maria
    Wallwiener, Markus
    Golatta, Michael
    Rom, Joachim
    Heil, Joerg
    Sohn, Christof
    Schneeweiss, Andreas
    Beckhove, Philipp
    Domschke, Christoph
    ONCOTARGET, 2017, 8 (62): : 104981 - 104991
  • [8] ANTI-TUMOR ANTIBODIES IN LUNG-CANCER PATIENTS IMMUNOFLUORESCENCE STUDY USING VARIOUS INDICATOR CELLS
    GORNY, MK
    JEZEWSKA, E
    KRZYSKO, R
    STAWARZ, M
    ZEROMSKI, J
    NEOPLASMA, 1979, 26 (06) : 729 - 736
  • [9] Poly G oligonucleotide enhances anti-tumor immune response among the patients with primary lung cancer
    Kobayashi, Nobuaki
    Shibata, Yuji
    Yamamoto, Masaki
    Sato, Takashi
    Shinkai, Masaharu
    Koizumi, Harumi
    Takahashi, Kenichi
    Kudo, Makoto
    Shirota, Hidekazu
    Kaneko, Takeshi
    CANCER RESEARCH, 2017, 77
  • [10] Cytokines Enhance the Anti-tumor Effects of Folate Conjugated Immunoglobulin
    Kondadasula, Sri Vidya
    Mani, Aruna
    Jones, Natalie
    Roda, Julie
    Lu, Yanhui
    Li, Hong
    Zhang, Xiaoli
    Jarjoura, David
    Lee, Robert J.
    Carson, William E.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 971 - 971